[1]王微微,林凯璇综述,张承,等.鳞状细胞癌抗原在宫颈鳞癌中的临床应用及研究进展[J].医学研究与战创伤救治(原医学研究生学报),2017,19(02):179-182.[doi:10.3969/j.issn.1672-271X.2017.02.017]

点击复制

鳞状细胞癌抗原在宫颈鳞癌中的临床应用及研究进展()

分享到62.8K

参考文献/References:

[1]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012［J］.Can J Clin,2015,65(2):87-108.
[2]NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer[OL]. National Comprehensive Cancer Network,2016.
[3]Kato H,Torigoe T.Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma［J］.Cancer,1977,40(4):1621-1628.
[4]王兰兰，许化溪．临床免疫学检验[M]．5版．北京：人民卫生出版社，2012：329-330.
[5]Jeong BK,Choi DH,Huh SJ,et al.The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix[J].Radiat Oncol J,2011,29(3):191-198.
[6]Farzaneh F,Shahghassempour S，Noshine B，et al.Application of tumor markers SCC-Ag,CEA and TPA in patients with cervical precancerous lesions[J].Asian Pac J Cancer Prev,2014,15(9):3911-3914.
[7]Chechlinska M,Kowalewska M,Brzoska-Wojtowicz E.Squamous cell carcinoma antigen 1 and 2 expression in cultured normal peripheral blood mononuclear cells and in vulvar squamous cell carcinoma [J].Tumour Biol,2010,31(6):559-567.
[8]Chechlinska M, Kowalewska M,Nowak R.Systemic inflammation as a confounding factor in cancer biomarker discovery and validation [J].Nat Rev Cancer,2010,10(1):2-3.
[9]Wang Y,Cui T,Du L,et al. The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma[J]. J Clin Lab Anal,2017,31(1).doi:10.1002/jcla.22020.
[10]欧洋华,贾西彪,陈岑,等.血清鳞状细胞癌抗原检测对宫颈鳞癌的诊断价值［J］.实用妇产科杂志，2013,29(5):345-347.
[11]Jao MS，Chang TC，Chang HP，et al．Long-term follow-up of cervical cancer patients with unexplained squamous cell carcinoma antigen elevation after post-therapy surveillance using positron emission tomography[J].J 0bstet Gynaecol Res,2010,36(5):1003-1008.
[12]廖勇梅,熊霞.鳞状细胞癌抗原在皮肤良性病变患者血清中的表达［J］.医学研究生学报，2015，28（6）:622-624.
[13]郭勇峰,郑曙民,李新燕.子宫颈癌患者可溶性尿激酶受体、鳞状细胞癌抗原、人乳头瘤病毒16、18联合检测的意义[J].肿瘤研究与临床,2014,26（12):837-839.
[14]Ikeda S,Yoshimura K,Onda T,et al.Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix[J].J Obstet Gynaecol Res,2012,38(10):1260-1265.
[15]于秀艳,张晓伟,吴雪峰,等.高危型HPV-DNA和SCCA在宫颈癌中的测定及临床意义[J]. 中国妇幼保健，2014,29：5525-5526.
[16]Li X，Zhou J，Huang K，et al.The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single institute study［J］.PLoS One,2015,10(4):1-12.
[17]Hu YY，Fan W，Zhang X，et al.Complementary roles of squamous cell carcinoma antigen and 18F-FDG PET/CT in suspected recurrence of cervical squamous cell cancer［J］.J Cancer，2015，6(3): 287-291.
[18]栾晓梅,张瑶,王诗卓,等．检测血清鳞状细胞癌抗原对宫颈鳞状细胞癌诊治及预后的临床意义［J］.中华医学杂志，2012，92（19):1330-1333.
[19]Kim DY,Shim SH,Kim SO,et al.Preoperative nomogram for the identification of lynph node metastasis in early cervical cancer［J］.Ｂr J Cancer,2014,110(1):34-41.
[20]Nakamura K，Okumura Y，Kodama J，et al.The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix [J].Gynecol Oncol,2010,119(1):81-86.
[21]王攀，晋其云，王东红，等. 血清鳞状细胞癌抗原和组织蛋白酶-D检测在宫颈鳞癌诊治中的应用价值［J］.中国老年学杂志，2016，36（11）：2680-2682.
[22]Salvatici M,Achilarre MT,Sandri MT, et al.Squamous cell carcinoma antigen (SCC-Ag) during follow up of cervical cancer patients:Role in early diagnosis of recurrence [J].Gynecol Oncol,2016,142(1):115-119.
[23]王静，田小飞，袁渊，等. 鳞状上皮细胞癌抗原在局部晚期宫颈鳞癌中的临床意义[J]．现代肿瘤医学，2013,21(3):636-638.
[24]Lekskul N,Charakorn C,Lertkhachonsuk AA,et al. The level of squamous cell carcinoma antigen and lymph node metastasis in locally advanced cervical cancer[J]. Asian Pac J Cancer Prev，2015,16(11):4719-4722.
[25]王承缙,张月香,李秋丽.血清鳞状上皮细胞癌抗原对子宫颈癌及CINⅢ的诊断价值［J］.国际妇产科学杂志，2013,40(3):280.
[26]李群，刘淑玉，刘红丽,等.血清鳞状细胞癌抗原水平变化在诊断子宫颈鳞癌复发中的临床意义[J].中华妇产科杂志，2015，50(2):131-136.
[27]Shimura K,Mabuchi S,Yokoi T,et al.Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice[J].J Gynecol Oncol，2013，24(4):321-329.
[28]Oh J,Lee HJ,Lee TS,et al.Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with locally advanced cervical cancer treated with radiation or chemoradiation[J].Obstet Gynecol Sci,2016,59(4):269-278.
[29]王红霞,丁晓萍,侯庆香,等.SCC-Ag在宫颈癌新辅助化疗前后的改变及临床意义[J].中国妇产科临床杂志, 2015,16(3):229-232.
[30]程金龙,徐冶,谢宏宇,等.宫颈癌新辅助化疗前后SCC-Ag水平与化疗敏感性的关系[J].现代肿瘤医学,2016,24(23):3790-3793.
[31]Ryu HK,Baek JS,Kang WD,et al.The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients [J]. Obstet Gynecol Sci，2015，58(5):368-76.
[32]Hsu KF,Wu CL,Huang SC,et al.Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy[J].Cancer Gene Ther,2008,15(8):526-534.
[33]Hamada K,Zhang T,Desaki J,et al.Carrier cell-mediated cell lysis of squamous cell carcinoma cells by squamous cell carcinoma antigen 1 promoter-driven oncolytic adenovirus[J].J Gene Med,2010,12(6):545-554.
[34]潘登华,何融泉,韦康来,等.人乳头状病毒E6蛋白与宫颈癌关系的研究进展[J].医学研究生学报,2014,27(11):1229-1232.

相似文献/References: